Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer
- 1 August 1998
- Vol. 52 (2) , 252-256
- https://doi.org/10.1016/s0090-4295(98)00149-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Is Prednisolone as Good as Flutamide in Hormone Refractory Metastatic Carcinoma of the Prostate?Journal of Urology, 1997
- Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide WithdrawalJournal of Urology, 1997
- Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.Journal of Clinical Oncology, 1997
- Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer.Journal of Clinical Oncology, 1995
- Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.Journal of Clinical Oncology, 1994
- Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate CancerJNCI Journal of the National Cancer Institute, 1994
- Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1993
- Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I TrialJNCI Journal of the National Cancer Institute, 1993
- Suramin and prostate cancer: The role of hydrocortisoneEuropean Journal Of Cancer, 1992
- Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaPThe Prostate, 1992